Navigation Links
Zimmer Holdings, Inc. Agrees to Sell $1 Billion of Senior Notes
Date:11/12/2009

WARSAW, Ind., Nov. 12 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH) announced today that it has agreed to sell $1.0 billion of its senior unsecured notes in an underwritten public offering consisting of $500.0 million of 4.625% notes due 2019 and $500.0 million of 5.75% notes due 2039. The 10-year notes were priced to yield 118 basis points above their Treasury benchmark, and the 30-year notes were priced at 135 basis points above their Treasury benchmark. The offering is expected to close on November 17, 2009.

The Company intends to use the net proceeds of the offering to repay the outstanding U.S. dollar denominated balance of its credit facility and for general corporate purposes, including the financing of its stock repurchase program.

Copies of the prospectus may be obtained by calling or e-mailing Banc of America Securities LLC at 1-800-294-1322 or dg.prospectus_distribution@bofasecurities.com, by calling Citigroup Global Markets Inc. toll free at 1-877-858-5407, or by calling J.P. Morgan Securities Inc. at (212) 834-4533.

This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction.

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2008 sales were approximately $4.1 billion. The Company is supported by the efforts of more than 8,000 employees worldwide.

This press release contains forward-looking statements regarding our intended use of proceeds and the anticipated closing of the notes offering, which are subject to risks and uncertainties, including the general economic conditions and other risks and uncertainties described in our Annual Report on Form 10-K for the year ended December 31, 2008 and subsequent quarterly reports. Actual results may differ materially from anticipated results. We do not undertake to update any forward-looking statements.

For more information about Zimmer, visit www.zimmer.com

SOURCE Zimmer Holdings, Inc.


'/>"/>
SOURCE Zimmer Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2009 Results
2. Comparative Study Shows Significant Bone In-growth and Advanced Clinical Outcomes Using Zimmers Trabecular Metal(TM) Technology
3. NeoStem Acquires China Biopharmaceuticals Holdings, Inc.; Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company
4. China Biopharmaceuticals Holdings, Inc. Shareholders Overwhelmingly Support Merger with NeoStem, Inc., a NYSE AMEX Listed Company Trading Under Symbol NBS
5. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 Fourth Quarter Earnings and 2010 Financial Guidance Webcast
6. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
7. Faced With Federal Prosecution, MountainView Agrees to Stop Harassment of RNs in Settlement With Labor Board
8. Lilly and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs
9. BioVex Agrees SPA With the FDA for a Pivotal Study With OncoVEX(GM-CSF) in Metastatic Melanoma and Announces Presentation of Phase II Results at ASCO
10. Service Outsourcing Opportunities in Medical Device Market worth US$26.77 Billion by 2014
11. Global Spinal Nonfusion Market to Reach Almost $2 Billion By 2013, According to Millennium Research Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/7/2017)... 2017  Diplomat Specialty Infusion Group, a brand of Diplomat Pharmacy, ... Iowa location. The ... features an ISO 7 cleanroom—the standard needed to compound intravenous (IV) ... level of pollutants. "Our new ... better serve our Iowa patients," said ...
(Date:6/2/2017)... 2017  NxStage Medical, Inc. (Nasdaq:  NXTM), a leading medical technology ... findings demonstrating positive biochemical outcomes related to more frequent ... data will be presented at the ERA-EDTA Congress being ... . The research was conducted ... in Europe (KIHDNEy) Cohort ...
(Date:5/30/2017)... , May 30, 2017 Therapix Biosciences Ltd. ... specializing in the development of cannabinoid-based drugs, today ... company overview at three upcoming scientific and investor ... LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology:
(Date:6/23/2017)... ... June 23, 2017 , ... Military Connection friend ... entry to the JFK Virgin Atlantic lounge. , Bensko is no stranger to ... years ago, Bensko dedicated her life to supporting our wounded veterans. A world-class photographer, ...
(Date:6/23/2017)... ... June 23, 2017 , ... Goodcents Deli Fresh Subs ... restaurant is located at 4210 SW 21st St. Topeka, Kan. 66604 (near 21st and ... Graham Restaurant Group who owns three other locations in the Topeka and Bonner Springs, ...
(Date:6/23/2017)... , ... June 23, 2017 , ... ... is essential, and two new videos highlight the importance of correctly using a ... Bruhn, Ph.D., who has done extensive research on consumer food safety habits. Dr. ...
(Date:6/23/2017)... ... ... 21 Middle East and South Asia Leaders Selected as Eisenhower Fellows , ... society in 11 countries across the Middle East and South Asia to embark on ... knowledge and ideas with the leading minds in their fields. , For the ...
(Date:6/23/2017)... ... 23, 2017 , ... PureLife Dental is pleased to announce that California Dental ... As part of the amalgam separator endorsement, all CDA members may purchase an ECO ... the retail value. This partnership between PureLife and CDA is especially timely as it ...
Breaking Medicine News(10 mins):